Rezolute (RZLT) Operating Expenses (2010 - 2026)
Rezolute (RZLT) posted Operating Expenses of $17.4 million for Q1 2026, down 28.3% sequentially from $24.2 million in Q4 2025, and down 13.27% YoY from $20.0 million in Q1 2025.
Rezolute (RZLT) Operating Expenses (2010 - 2026) Analysis & Trends
Rezolute has reported Operating Expenses for 17 years, with the latest figure at $17.4 million in Q1 2026.
- Quarterly Operating Expenses fell 13.27% year-over-year to $17.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $87.3 million (up 13.1% YoY) and the FY2025 annual result came in at $79.9 million, up 13.45% from the prior year.
- Operating Expenses slipped to $17.4 million in Q1 2026 per RZLT's latest filing, from $24.2 million in the prior quarter.
- Over five years, Operating Expenses peaked at $25.8 million in Q2 2025 and troughed at $10.2 million in Q3 2022.
- A 5-year average of $17.0 million and a median of $16.9 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2026: Operating Expenses jumped 96.13% in 2022, then dropped 13.27% in 2026.
- Over 5 years, Operating Expenses stood at $14.4 million in 2022, then rose by 5.57% to $15.2 million in 2023, then advanced by 12.41% to $17.1 million in 2024, then jumped by 41.81% to $24.2 million in 2025, then decreased by 28.3% to $17.4 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $17.4 million, $24.2 million, and $19.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | 17.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.37 Mn |
| Dec 31, 2025 | 24.22 Mn |
| Sep 30, 2025 | 19.82 Mn |
| Jun 30, 2025 | 25.85 Mn |
| Mar 31, 2025 | 20.02 Mn |
| Dec 31, 2024 | 17.08 Mn |
| Sep 30, 2024 | 16.94 Mn |
| Jun 30, 2024 | 23.10 Mn |
| Mar 31, 2024 | 16.21 Mn |
| Dec 31, 2023 | 15.19 Mn |
| Sep 30, 2023 | 15.91 Mn |
| Jun 30, 2023 | 14.24 Mn |
| Mar 31, 2023 | 17.14 Mn |
| Dec 31, 2022 | 14.39 Mn |
| Sep 30, 2022 | 10.22 Mn |
| Jun 30, 2022 | 11.30 Mn |
| Mar 31, 2022 | 10.75 Mn |
| Dec 31, 2021 | 12.15 Mn |
| Sep 30, 2021 | 7.64 Mn |
| Jun 30, 2021 | 6.64 Mn |